Fig. 2.
Fig. 2. Spleen, lymph node, and thymus cells from CD44 gene mutated mice lack surface expression of CD44. Lymph node cells, spleen cells, and thymocytes were stained with anti-CD44 KM81 supernatants and secondary labeled with PE-conjugated goat antirat, PE-conjugated anti-CD44 KM201, or PE-conjugated anti-CD44 IM 7.8.1 (pgp-1). Mice with homozygous disruptions in the CD44 gene show no detectable surface expression. FCM data were collected for viable lymphocytes according to side scatter (SSC) and foreward scatter (FSC).

Spleen, lymph node, and thymus cells from CD44 gene mutated mice lack surface expression of CD44. Lymph node cells, spleen cells, and thymocytes were stained with anti-CD44 KM81 supernatants and secondary labeled with PE-conjugated goat antirat, PE-conjugated anti-CD44 KM201, or PE-conjugated anti-CD44 IM 7.8.1 (pgp-1). Mice with homozygous disruptions in the CD44 gene show no detectable surface expression. FCM data were collected for viable lymphocytes according to side scatter (SSC) and foreward scatter (FSC).

Close Modal

or Create an Account

Close Modal
Close Modal